AstraZeneca to acquire Modella AI to speed oncology drug research
13.01.2026
SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs. The companies did not disclose financial terms.